Cancer-derived ev

Show results for

Unknown (725)
Genomics (114)
Proteomics (104)
Transcriptomics (58)
Metabolomics (14)
Other (2)

Organisms

Aerococcus urinae NBRC 15544 = CCUG 36881 (83)
Andropogon gerardi (83)
Bacteria (83)
Bartonella quintana JK 31 (83)
Canis lupus familiaris (83)
Cnidaria (83)
Ectopseudomonas oleovorans CECT 5344 (83)
Ensifer adhaerens (83)
Halictus scabiosae (83)
Human immunodeficiency virus 1 (83)
Mesocricetus auratus (83)
Miscanthus x giganteus (83)
Mus musculus (83)
Panicum virgatum (83)
Pseudomonas aeruginosa PA103 (83)
Pseudomonas aeruginosa SJTD-1 (83)
Rabies virus Nishigahara RCEH (83)
Rattus norvegicus (83)
Rattus rattus (83)
Rhodococcus jostii RHA1 (83)
Rhodopseudomonas palustris (83)
Schizosaccharomyces pombe 927 (83)
Sorghastrum nutans (83)
Staphylococcus aureus (83)
Streptococcus dysgalactiae subsp. equisimilis SK1249 (83)
Streptococcus pneumoniae (83)
Streptomyces coelicolor A3(2) (83)
Homo sapiens (64)
Mus musculus (26)
Rattus norvegicus (1)

Organisms

Homo sapiens (63)
Mus musculus (20)
Mus musculus musculus (1)
Rattus norvegicus (1)

Repository

ENA (100)
pride (83)
geo (52)
biostudies-arrayexpress (21)
MetaboLights (12)
iProX (9)
jPOST (7)
MassIVE (5)
EGA (1)
MetabolomicsWorkbench (1)
NODE (1)

Tissue

Cell culture (30)
Epithelial cell (16)
Blood plasma (6)
Blood (5)
Breast (5)
Colon (4)
Fibroblast (4)
Permanent cell line cell (4)
Extracellular vesicle (3)
Kidney (3)
Mesothelial fibroblast (3)
Pleural mesothelium (3)
B cell (2)
Bladder (2)
Breast cell line (2)
Cell suspension culture (2)
Fibroblast of lung (2)
Lung (2)
Monocyte (2)
Primary cell (2)
Prostate gland (2)
Urine (2)
Keratinocytes (1)
Cell line (1)
Blood cell (1)
Blood platelet (1)
Blood-brain barrier (1)
Brain (1)
Breast epithelium (1)
Cerebral cortex (1)

Disease

Breast cancer (23)
Prostate adenocarcinoma (6)
Colon cancer (5)
Malignant pleural mesothelioma (3)
Urinary bladder cancer (3)
Melanoma (2)
Multiple myeloma (2)
Ovarian cancer (2)
Renal cell carcinoma (2)
Cancer (1)
Lung cancer (1)
Acute monocytic leukemia (1)
Brain cancer (1)
Brain glioblastoma multiforme (1)
Endometrial cancer (1)
Gastric adenocarcinoma (1)
Glioblastoma (1)
Inflammatory bowel disease (1)
Liver cancer (1)
Lung non-squamous non-small cell carcinoma (1)
Lung squamous cell carcinoma (1)
Malignant neoplasm of ovary (1)
Myeloid leukemia (1)
Ovary epithelial cancer (1)
Pancreatic ductal adenocarcinoma (1)
Prostate cancer (1)
Skin melanoma (1)
Small intestine neuroendocrine neoplasm (1)
Ulcerative colitis (1)

Technology Type

Mass Spectrometry (84)
Shotgun proteomics (46)
Bottom-up proteomics (22)
Data-independent acquisition (10)
Mass spectrometry (7)
Data-dependent acquisition (7)
Mass spectrometry assay (5)
Affinity purification coupled with mass spectrometry proteomics (4)
DiaPASEF (3)
SWATH MS (3)
Gel-based experiment (2)
SRM/MRM (2)
EI (1)
All-ion fragmentation (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (6)
Gas Chromatography MS - positive (4)
NextSeq 500 (3)
Orbitrap Exploris 480 (2)
Liquid Chromatography MS - negative - hilic (2)
Liquid Chromatography MS - positive - hilic (2)
DNBSEQ-G400 (1)
Illumina HiSeq 1000 (1)
Illumina HiSeq 2500 (1)
Orbitrap Fusion (1)
Q Exactive HF (1)
TimsTOF Pro (1)
TimsTOF Ultra (1)
Capillary electrophoresis MS - (1)
Gas Chromatography MS - (1)
Liquid Chromatography MS - alternating - hilic (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2025 (56)
2023 (28)
2024 (26)
2026 (19)
2022 (14)
2014 (7)
2019 (7)
2021 (6)
2020 (5)
2015 (4)
2016 (3)
2010 (3)
2008 (2)
2017 (2)
2013 (1)
2018 (1)

CHEBI ID

CHEBI:16708 (5)
CHEBI:17822 (4)
CHEBI:15978 (4)
CHEBI:18257 (4)
CHEBI:28044 (4)
CHEBI:16737 (4)
CHEBI:16680 (3)
CHEBI:26271 (3)
CHEBI:25094 (3)
CHEBI:22660 (3)
CHEBI:18186 (3)
CHEBI:16811 (3)
CHEBI:28300 (3)
CHEBI:16750 (3)
CHEBI:24898 (3)
CHEBI:25017 (3)
CHEBI:15428 (3)
CHEBI:16958 (3)
CHEBI:15741 (3)
CHEBI:6650 (3)
CHEBI:16335 (3)
CHEBI:17568 (3)
CHEBI:27266 (3)
CHEBI:15891 (3)
CHEBI:16449 (3)
CHEBI:32816 (3)
CHEBI:16027 (3)
CHEBI:30915 (3)
CHEBI:16199 (3)
CHEBI:27897 (3)

Metabolite Name

Uracil (3)
Glutathione (3)
Ornithine (3)
Adenosine (3)
Adenine (3)
Beta alanine (2)
Hexose (2)
Phe-Glu (2)
Pyruvic acid (2)
Tolazoline (2)
1-Palmitoyl-sn-glycero-3-phosphocholine (2)
1-Myristoyl-sn-glycero-3-phosphocholine (2)
Cholesterol (2)
Stearidonic Acid (2)
Heptadecanoic acid (2)
Taurine (2)
Serine (2)
Proline (2)
Lysine (2)
Cysteine (2)
Adenine (2)
3-phosphoglycerate (2)
Phenylalanine (2)
Tyrosine (2)
Urea (2)
Methionine (2)
Creatinine (2)
Glutamine (2)
Alanine (2)
Valine (2)

First Public Date

2025 (29)
2024 (16)
2023 (16)
2026 (10)
2022 (9)
2019 (7)
2021 (4)
2014 (3)
2020 (2)
2018 (1)
2017 (1)
2016 (1)
2015 (1)

Study type

Transcription profiling by array (8)
RNA-seq of coding RNA (7)
Unknown experiment type (2)
MicroRNA profiling by high-throughput sequencing (1)
Transcription profiling by tiling array (1)
Transcription profiling by RT-PCR (1)
RNA-seq of total RNA (1)

Release Date

2025 (116)
2022 (108)
2023 (105)
2024 (89)
2021 (84)
2020 (70)
2019 (49)
2018 (33)
2017 (27)
2026 (15)
2016 (14)
2014 (11)
2015 (9)
2010 (5)
2013 (4)
2008 (3)
2012 (2)
2011 (1)
2009 (1)

Lab affiliation

CRUK - Beatson Institute for Cancer Research - Switchback Rd, Bearsden, Glasgow G61 1BD - United Kingdom (4)
University of Vienna, Faculty of Chemistry, Department of Analytical Chemistry (3)
Department of Chemistry and Biomolecular Sciences, University of Ottawa, Canada (2)
1 - Cancer Biology & Epigenetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal 2 - CI-IPOP @RISE-Associated Laboratory and Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC), R. Dr. António Bernardino de Almeida, Porto, Portugal (1)
1 Children’s Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children’s Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA (1)
1) Vascular Biology Program, Boston Children's Hospital, Boston, MA, United States 2) Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, MA, United States (1)
1. Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands 2. Netherlands Proteomics Centre, Padualaan 8, 3584 CH Utrecht, The Netherlands (1)
1. Gene Regulation, Stem Cells and Development group, PTS, Granada GENyO, Pfizer-University of Granada-Andalusian Regional Government Centre for Genomics and Oncological Research, Avenida de la Ilustración 114, 18016 Granada, Spain. 2. Department of Biochemistry and Molecular Biology I, Faculty of Science, University of Granada, Avenida Fuentenueva s/n, 18071 Granada, Spain. 3. Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain. (1)
1. Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan. 2. Molecular Medicine Research Center, Chang Gung University, Taoyuan 33302, Taiwan. 3. Department of Otolaryngology-Head and Neck Surgery, Chang Gung Memorial Hospital, Linkou 33305, Taiwan. 4. Research Center for Food and Cosmetic Safety, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan 33302, Taiwan. (1)
1Instituto de Ciências Biomédicas, Departamento de Parasitologia, Universidade de São Paulo, USP, São Paulo, Brazil. (1)
Angiogenesis and Tumor Microenvironment Lab The Swiss Institute for Experimental Cancer Research (ISREC) School of Life Sciences Ecole Polytechnique Fédérale de Lausanne (EPFL) Swiss Federal Institute of Technology, Lausanne, Switzerland (1)
Assistant Professor, Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center (1)
Assistant Professor, Departments of Oncology & Pathology, McGill University Principal Investigator, Cancer Research Program, MUHC-RI 1001 Decarie Blvd, EM2.2218 514.934.1934 ext 76307 Montréal, Canada (1)
Associate Professor, Cedars-Sinai Medical Center, Surgery (1)
Associate Professor, Department of Pathology, Faculty of Medicine, The University of Hong Kong (1)
Baylor College of Medicine (1)
Biomolecular Mass Spectrometry & Proteomics Group Utrecht University (1)
CRUK Beatson Institute, Switchback Road, Glasgow G61 1BD, UK. (1)
Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP), Portuguese Oncology Institute of Porto, Porto, Portugal (1)
Cedars-Sinai Medical Center (1)
Charles E. Foulds, Ph.D. Assistant Professor Lester and Sue Smith Breast Center Baylor College of Medicine (1)
Core Facility Proteomics, Department of Clinical Chemistry, University Medical Center Goettingen, Germany (1)
Core facilities National Institute of Health Viale Regina Elena 299 00161 Rome Italy (1)
Cornell University (1)
Department of Biochemistry, Soonchunhyang University, College of Medicine, 31 Suncheonhyang 6-gil, Bongmyeong-dong, office# 310, Cheonan-si, Chungcheongnam-do, 31151, Republic of Korea (1)
Department of Biomedical and Clinical Sciences, Bojmar Lab, Linköping University, Linköping, Sweden (1)
Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands. (1)
Department of Chemistry and Biomolecular Sciences, University of Ottawa, Canada (lab head) (1)
Department of Innovative Technologies in Medicine & Dentistry, University of "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy (1)
Department of Life Sciences, Pohang University of Science and Technology, Pohang 790-784, Republic of Korea (1)

Previous page
1 / 102
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 102
Next page

Sort by:

Relevance

Page size

Branched-chain ketoacids derived from cancer cells modulate macrophage polarization and metabolic reprogramming

Macrophages are prominent immune cells in the tumor microenvironment that can be educated into pro-tumoral phenotype by tumor cells to favor tumor growth and metastasis. The mechanisms that mediate a mutualistic relationship between tumor cells and macrophages remain poorly characterized. Here, w...

2022-10-03 | MTBLS4497 | MetaboLights

A reductionist approach using primary and metastatic cell-derived extracellular vesicles reveals hub proteins associated with oral cancer prognosis

Not available

ORGANISM(S): Homo sapiens

ST001755 | MetabolomicsWorkbench

Whole proteome and transcriptome analysis of cancer-derived EVs overlap in specific pathways and distinct EV population

PRJNA887099 | ENA

Integration of the whole proteome and transcriptome reveals a strong correlation between the protein and mRNA in a distinct population of cancer-derived EVs

Extracellular vesicles (EVs) are particles of different sizes, covered by a lipid bilayer membrane and containing highly heterogeneous cargo. Cancer cell-derived EVs have been the main object of an extensive investigation in the field because they carry cancer-specific molecular cargo and can promot...

ORGANISM(S): Homo sapiens (Human)

2025-04-16 | PXD038011 | Pride

Cancer-derived ev Transcriptomics Proteomics Prostate cancer

Transcriptomic profiling of 30 serum EV Sample

PRJNA1079826 | ENA

Whole proteome and transcriptome analysis of cancer-derived extracellular vesicles overlap in specific pathways and distinct EV populations

Extracellular Vesicles (EVs) are particles of different sizes, covered by a lipid bilayer membrane and containing highly heterogeneous cargo. Cancer cell-derived EVs have been the main object of an extensive investigation in the field because they carry cancer-specific molecular cargo and can promot...

ORGANISM(S): Homo sapiens (Human)

2025-04-16 | PXD038518 | Pride

Proteomics label-free large oncosomes exosomes extracellular vesicles

Tumor-derived EV miRNA signatures surpass total EV miRNA in supplementing mammography for precision breast cancer diagnosis.

Not available

S-EPMC11519808 | biostudies-literature

Proteomic Profiling Of Bladder Cancer Patients-Derived Extracellular Vesicles

Extracellular vesicle (EV) proteomics holds great promise for non-invasive cancer biomarker discovery. This study presents the first comprehensive proteomic characterization of EVs from tissue, plasma, and urine, focusing on bladder cancer BlCa. EVs were isolated via ultracentrifugation, and their c...

ORGANISM(S): Homo sapiens (Human)

2026-06-08 | PXD062618 | Pride

Extracellular vesicles proteomics liquid biopsy biomarker bladder cancer

EV DNA from pancreatic cancer patient-derived cells harbors molecular, coding, non-coding signatures and mutational hotspots.

Not available

S-EPMC11882941 | biostudies-literature

Whole proteome and transcriptome analysis of cancer-derived EVs overlap in specific pathways and distinct EV population

ORGANISM(S): Homo sapiens

2025-04-22 | GSE214804 | GEO

Previous page
1 / 102
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 102
Next page

Sort by:

Relevance

Page size

1017 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets